PIK3CA and rhabdomyosarcoma: A genome-wide investigation, conducted in 2014 on 147 RMS samples, found alterations of the RTK-RAS-PIK3CA axis in 93% of rhabdomyosarcoma cases, and in particular, PIK3CA was mutated in 7.4% of fusion-negative samples included in the study [25].